Introduction
Functional gene-set (including signaling pathways) enrichment analysis has been widely used for biological interpretation of next-generation sequencing (NGS) data [14] . We designed seq2pathway for novel functional analysis of NGS data by taking the effect of non-coding loci and their experimental significance scores into consideration. Applying seq2pathway to both ChIP-seq and transcriptomic data, our recent studies revealed novel cis-regulatory elements that explain genome-wide association study (GWAS) identification [27] or can be in vivo defined [8] . This R/Bioconductor package offers Bioconductor users enhanced capability to discover collective pathway effects caused by both coding genes and cis-regulation of non-coding elements.
Main features
The main features of seq2pathway are outlined in six points below that provide additional insights into the NGS data.
"seq2pathway" is a two-step algorithm consisting of "seq2gene" and "gene2pathway" components. Users can run two steps jointly or separately.
"seq2gene" can aggregate locus significance scores such as binding affinity from ChIP-seq [27] or odds ratio from GWAS into gene-level scores per sample, free of gene length bias.
"gene2pathway" provides four gene-set enrichment analytic approaches (FAIME [26] , KS-rank, cumulative-rank, and Fisher's exact test (FET)), free of gene-set bias.
"seq2pathway"can estimate empirical significance of pathway enrichment, which overcomes the gene-set analytic bias caused by gene length or gene-set size [26] .
"seq2pathway" can analyze customized ontology inputs (GO, KEGG pathway, Disease Ontology, etc.) and, importantly, can test in-house defined ontologies in conjunction with public canonic pathways.
"seq2pathway" calculates comparable pathway-level scores for the same sample (or samples in the same group), even measured by different NGS technologies, facilitating the development of systematic analysis of NGS.
These features are essential to develop systematic study addressing open questions in the field of NGS data mining. We have recently used seq2pathway derived individualized pathway scores to perform dynamic mechanism analysis among leukemic and hematopoietic stem cells and revealed a favorable prognostic signature for acute myeloid leukemia [28] . For ChIP-seq data, the distribution of binding affinity, which greatly depends on the peak calling algorithm, will result in a variable range of locus-level significance scores. Seq2pathway deals with this challenge of identifying signals across the entire spectrum of high confidence/enrichment (peaks) and low confidence/enrichment (noise) by taking into account a ranked list of pre-threshold significance scores. Specifically, seq2pathway aggregates log-transformed p-values from loci into gene-level scores and then ranks the gene-level scores genome-wide.
To highlight these features, we demonstrate the application of seq2pathway on a variety of different NGS datasets (ChIP-seq, GWAS or whole-genome sequencing identified SNPs, and RNA-seq) in the following case study section. We also provide the ontological resources and R code for these case studies. Finally, we summarize take home points for users to apply seq2pathway.
Instructions for installation, detailed functions, and functional parameters can be found in the online vignette of the seq2pathway package from Bioconductor.
seq2pathway flowchart, including seq2gene and gene2pathway components
To provide users with a straightforward understanding of how the two-step method works, we give a flowchart ( Figure  1 ) explaining seq2pathway that consists of seq2gene and gene2pathway components. 
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Step 1: seq2gene Step 2: gene2pathway
Figure 1: seq2pathway two-step flowchart. The inputs are on the top-left panel in square, and the outputs are on the bottom-right panel. A full pipeline analysis can be achieved by calling runseq2pathway in the package. Alternatively, users can call the two main functions runseq2gene and gene2pathway_test in series.
seq2gene pseudo-code
The seq2gene step links both coding and non-coding regions to coding genes in a many-to-many mapping [27] . Using seq2gene with a search radius of 100k bps, our recent in vivo study defined a novel cis-regulatory element from both ChIP-seq and transcriptomic data [8] . This function can find certain types of transcripts annotated by GENCODE in both the human and mouse genome. Figure 2 is the pseudo code for the function seq2gene [27] . To perform the basic bisect algorithm with respect to exon and transcript separately, we used ENSEMBL IDs as the key index (Table 1) . locate the nearest exon(J) for peak(i) by the basic bisect algorithm 6.
if peak(i) resides inside exon(J) 7.
report peak(i) with exon(J) 8. endif 9.
while exon(x) intersecting with peak(i) 10.
report peak(i) with exon(x) 11.
exon 
gene2pathway algorithm
The analysis of gene-sets is superior to single-gene analysis in regard to noise and dimensional reduction, as well as its desired biological interpretability [17] . However, most gene-set analysis methods impose inherent limits on low cross-dataset comparison or reproducibility from gene-by-sample measurements, as only the genes measured by all collected platforms can be interrogated together. Improved gene-set analyses condense transcriptomic data from gene-by-sample measurements (gene profiles) to gene-set-by-sample measurements (gene-set profiles), which are genecoverage-difference tolerable and a breakthrough in genome analytics coordinates. Such gene-set-by-sample analyses facilitate the integration and analysis of multiple datasets, platforms, or layers of omics-data, by assigning them into a uniform gene-set scale. We apply the improved gene-set analysis method [26] here.
However, gene-set analyses are often prone to various sources of bias (e.g. gene length bias, gene-set size bias). The seq2pathway empirical p-value adjusts gene length bias by assigning the observed scores to all genes in the human genome randomly. The seq2pathway method also adjusts gene-set size bias by the calculation of a FAIME score [26] (See Figure 3, Equation 2 for details).
Another concern for analysis of NGS datasets is that the assignment of significance scores varies greatly depending on the peak calling algorithm used in the analysis. We therefore applied a straightforward normalization (z-transfer) to gene-set scores that varied across samples and datasets. We have recently shown that the normalization enables multi-resource data integration and biologically functional interpretation by working on the same scale of functional gene-sets [28] . Figure 3: Procedure for determining pathway profiles for each sample using microarray expression (FAIME profiles -Published in [26] ). There are three equations applied in series that calculate a gene-set score. The 2nd equation adjusts the gene-set size effects.
2 Case study
Data
Seq2pathway complements other NGS analytic approaches by providing Bioconductor users a new tool to put functional insight into NGS data systematically. To demonstrate its novelty, we perform the following case studies on a variety of different NGS datasets (ChIP-seq, GWAS or whole-genome sequencing identified SNPs, and RNA-seq) ( Table  2 ). Seq2pathway is further complementary to other approaches in terms of its studying on more customized knowledge database. Therefore in case studies using ChIP-seq and RNA-seq data, we demonstrate the test on GO databases. In the case study of SNP data, we demonstrate the test on the Human Disease Ontology database and the Reactome pathway database ( Table 3 ).
Note that the MSigDB curated GO omitted gene-sets for very broad categories (such as Biological Processes) and very specific gene-sets with fewer than 9 genes. Seq2pathway loads this curated GO database because it has been widely used for gene-set enrichment analysis (GSEA) [17] . Seq2pathway also includes gene-sets derived from R object "org.Hs.egGO2EG 2.14.0" based on GO.db 2.14.0. 
Highlights
Importantly, seq2pathway provides Bioconductor users a new tool to provide functional insight on NGS data systematically. We highlight the expected and novel results obtained only with seq2pathway (Table 4) followed by the R code to apply seq2pathway. In the main manuscript, we also compared the results of seq2pathway to that of Genomic Regions Enrichment of Annotations Tool (GREAT) [14] and ChIP-Enrich [22] for the ChIP-seq experiment. The purpose of developing seq2pathway is to provide a novel and flexible Bioconductor tool for functional data mining. Users can apply, separately or jointly, a two-step algorithm consisting of "seq2gene" and "gene2pathway" components. In the case study using ChIP-seq data, we demonstrate use of functions runseq2gene() and gene2pathway_test() in series and a calling of the joint function runseq2pathway().
ChIP-seq data analysis 2.3.1 Discover over-represented GO terms from H3K27me3 enriched peaks
Seq2pathway has the option to assign non-exon regions to a broader range of neighboring genes than the nearest one, facilitating the study of functional non-coding elements [27] . Seq2pathway then considers the contribution of sequence-level statistics to the gene-set enrichment scores.
Overcome the bias of gene length and gene-set size
Gene-set analyses are often prone to various sources of bias (e.g. gene length bias, gene set size bias, linkage disequilibrium patterns). We first show that, in this case study on ChIP-seq data, for gene-sets with five or more genes the calculation of empirical p-values is sufficient to address both potential issues (Figure 4) . We observed similar patterns of empirical p-values repeating the simulation 1000 times or 100 times. 
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Figure 4: Boxplots of gene-set sizes (panel A) and averaged lengths of genes within gene-sets (panel B) across different empirical p-value ranges. We split the empirical p-values resulting from this case study into eleven bins. In each subpanel, the x-axis is the top value of each bin, and the y-axis is the log10 transformed gene-set size (top) or gene length (bottom). Each box shows the 25th and 75th percentiles of the data and the median. The "whiskers" extend to the most extreme data point within 1.5 times the interquartile range from the box. Additionally, a dotted line shows the average values across all boxes.
Method comparison
We looked into the H3K27me3 enriched loci in the GSM12878 cells downloaded from the ENCODE compendium. To make the seq2pathway analytic results comparable with the results of GREAT [14] and ChIP-Enrich [22] , we set a 5k bp search radius.
Our results indicated that seq2pathway concentrates better with less identifications of significant GO terms than GREAT [14] or ChIP-Enrich [22] (Figure 5 ) and is the only method to reveal the significance of GO:0003705 (distal enhancer region for RNA polymerase II), a molecular function (MF) significantly enriched by bivalent genes marked with both H3K4me3 and H3K27me3 [12] . 
R code
load ChIP-seq enriched peaks > library("seq2pathway.data") > library("seq2pathway") > H3K27me3 <-read. In the seq2pathway package, runseq2pathway() is one of the key functions. The input file contains sequence-level measurements of genomic regions (including genomic coordinates and ChIP-seq enrichment scores or -log p-values), and the output is statistics on gene-set level. # This step may be time-consuming and depends on the length of peaks # and the parameter B used to estimate empirical P-value. # Users can take the demo data in the seq2pathway package with a smaller B value # for practice (see vignette). > > seq2pathway_5KB <-runseq2pathway(inputfile=H3K27me3, + search_radius = 5000, + genome = "hg19", + FAIMETest=TRUE, B=1000, + FisherTest=TRUE) > save(seq2pathway_5KB,file="seq2pathway_5KB_fullresult.rData",compress=T)
Example 2: a separate run
In the seq2pathway package, runseq2gene() and gene2pathway_test() are the key functions. The input file of runseq2gene() is sequence-level measurements of genomic regions (including genomic coordinates and ChIP-seq enrichment scores or -log p-values), and the output is statistics on the gene level. The input file of gene2pathway_test() is gene-level measurements (runseq2gene outputs or RNA-seq measurements), and the output is statistics on the geneset level.
# Alternatively, the user can call two steps separately with more flexibility. > > seq2gene_5KB <-runseq2gene(inputfile=H3K27me3, search_radius=5000, genome="hg19") > names(seq2gene_5KB) [1] "seq2gene_FullResult" "seq2gene_CodingGeneOnlyResult" > # This step takes a while for large data sets by calling function collapseRows() in the R package{WGCNA > > dat_collapsed <-Peak_Gene_Collapse(input = peak_anno_score,collapsemethod = "MaxMean") > dim(dat_collapsed) [ 8.162426 > save(dat_collapsed, file="seq2gene_5KB_collapsed_03102015.rData",compress=T) > > dat_CP <-data.frame(dat_collapsed[, c(2:ncol(dat_collapsed))]) > rownames(dat_CP) <-rownames(dat_collapsed) > colnames(dat_CP) <-colnames(dat_collapsed)[2:ncol(dat_collapsed)] # This step takes a while for large data sets when EmpiricalTest=TRUE # > > GO_BP_FAIME <-gene2pathway_test(dat = dat_CP, DataBase = GO_BP_list, + method = "FAIME", genome="hg19", + FisherTest=FALSE, EmpiricalTest=TRUE) > colnames(GO_MF_FAIME) [3] <-"signalvalue2pathscore_Pvalue" > save(GO_MF_FAIME,file="seq2gene_5KB_GO_MF_FAIME_03102015.rData",compress=T)
For method comparison, we ran the following R code to get the enriched GO terms using R package chipenrich [22] and used the online tool GREAT [14] . We expect seq2pathway to recapture established knowledge and provide novel insights into the ChIP-seq data.
> library(chipenrich) > result_5KBfrom_tss <-chipenrich(H3K27me3bed, genome = "hg19", + genesets =c('GOBP','GOCC','GOMF'), locusdef = "5kb", + method = "chipenrich", fisher_alt = "two.sided", use_mappability = F, + qc_plots = T) > dim(result_5KBfrom_tss$peaks) [1] 6606 > length(unique(result_5KBfrom_tss$peaks$gene_symbol)) [1] 3944 > save(result_5KBfrom_tss,file="result_5KBfrom_tss.rData") > # The common identification between seq2pathway and GREAT tools. [2] "Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate." [3] "Catalysis of the reaction: protein + ATP = protein phosphate + ADP. This reaction is the phosphorylation of proteins. Mitogen-activated protein kinase; a family of protein kinases that perform a crucial step in relaying signals from the plasma membrane to the nucleus. They are activated by a wide range of proliferation-or differentiation-inducing signals; activation is strong with agonists such as polypeptide growth factors and tumor-promoting phorbol esters, but weak (in most cell backgrounds) by stress stimuli." [4] "Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator." [5] "Catalysis of the transmembrane transfer of a calcium ion by a channel that opens when a specific ligand has been bound by the channel complex or one of its constituent parts." [6] signalvalue2pathscore_Pvalue Intersect_Count GO:0007409 0 66 > # Users also have a chance to obtain novel insight through application of approaches # provided in the seq2pathway package. > > FAIME_BP_Empirical_FDR$Des [1] "The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus." [2] "The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline." [3] "Generation of a long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells." [4] "Any process that stops, prevents or reduces the rate or extent of cell proliferation." [5] "Formation of a prolongation or process extending from a cell, e.g. a flagellum or axon." [6] "Any process that affects the structure and integrity of a protein by altering the likelihood of its degradation or aggregation." [7] "Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides, catalyzed by RNA polymerase II." [8] "Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle." >
SNP data analysis
Great advances have been made in the field of genetic analysis over the last decades, while the availability of millions of single nucleotide polymorphism (SNP) data has increased. However, studies elucidating the genetic basis of complex disease were cherry-picking, and we lack systematic analytic tools for this process. In this case study, we show that by applying seq2pathway on SNP data, we can recapture the "bone development" related GO terms discovered by GREAT [14] and reveal new pathways (eg, elastic fibre formation, bone resorption disease).
Discover over-represented Disease Ontology terms from height-associated SNPs
Specifically, we searched "height" trait from NHGRI compendium on February 2015. We got 521 SNPs from 21 studies and innovatively apply the seq2pathway approach on functional analysis of 460 height-associated human SNPs with reported p-values.
We demonstrate here the use of the seq2pathay approach to discover over-represented pathways defined in the Reactome database, human disease ontologies, and other pre-defined functional gene-sets. Note that seq2pathway does not adjust for the effect of population size on meta-analysis.
Overcoming the bias of gene length, gene-size, and linkage disequilibrium
We again investigate the effect of gene length on empirical p-values using the FAIME method. We find that FAIME score adjusts gene-set bias but its empirical p-value is prone to favorite small gene-sets with 1 or 2 gene members (Figure 6 A1 ). This bias could be adjusted when applying this method on gene-sets with 3 or more genes ( Figure 6 A2 ) and fully corrected for gene-set with five or more genes (Figures 6 A3, 4 A1) . Additionally, gene-length bias doesn't affect the distribution of reported FAIME scores (Figure 6 D) .
Additionally, As we collapse the significance of neighboring SNPs with preference to higher linkage disequilibrium (LD), our method should overcome the common bias of linkage disequilibrium in pathway analysis of SNPs. To test this hypothesis, we calculated the average European LD scores for SNP-SNP pairs that were mapped to any genes in a GO BP term. We used the online tool to derive LD scores (threshold at 0.2) from the 1000 Genomes Project Haploreg version 3 [24] . All together, 433 SNPs were mapped to one or more GO BP genes. Although all averaged LD scores per GO term are higher than 0.6, the distribution of these LD scores has no significant bias in terms of gene-set enrichment (Figure 6 C) . We observed the similar results for another ethnic population which is as expceted, as the human height trait-SNPs were not collected from ethnic specific GWAS. Additionally, Panel D is the boxplot of gene-set sizes across different FAIME score ranges. We split the empirical p-values into eleven bins and the FAIME scores into 44 bins. In each subpanel, the x-axis is the top value of each bin, and the y-axis is the log10 transformed gene-set size (A, D), gene length (B), or averaged LD scores for any pair of SNPs that were mapped to genes in the same GO BP (C).
Method comparison
For the method comparison, we ran the GREAT online tool on these 460 human height-associated SNP loci and compared the output with the seq2pathway results (using the default searching parameter, BinomFdrQ < 0.05, observed regions > 3, and region fold enrich > 2).
Again, we found seq2pathway is more sensitivity than GREAT for test of gene-set enrichment in terms of the number of identified GO terms (Figure ??) . Additionally, 14% of seq2pathway pathway-score identified GO terms recapture previously predicted height-associated biological processes, more than GREAT (0.6%) did in this case study.
Notably, four out of the six most top enriched diseases ontology terms (FET, count >3, p < 0.01) are related directly to bone disorder, including bone remodeling disease, arthropathy, osteoporosis, and bone resorption disease. Compared to the GREAT report on the same SNP list, the new insights into "bone resorption disease" and "elastic fibre formation"are caused by our new seq2gene mapping method [27] and the flexibility to analyze gene-set databases of interests. We found that seq2pathway applying both the hypergeometric test (theoretic p < 0.05) and the FAIME scores (empirical p < 0.01) recaptures the expected bone development associated biological processes and cell components, such as "Chondrocyte Differentiation" (GO:0002062) [16] .
Interestingly, the valuable biological processes obtained only with seq2pathway (empirical p < 0.05) include"In Utero Embryonic Development" (GO:0001701) that was predicted by a comprehensive study on human height [25] (Figure 1 in the main manuscript). > res.GO <-runseq2pathway(inputfile=bed, + search_radius=5000, # be comparable to GREAT + genome="hg19", SNP= TRUE, + DataBase="GOterm", + FAIMETest=TRUE, min_Intersect_Count=1) # be comparable to GREAT > > res.Reactome <-runseq2pathway(inputfile=bed, + search_radius=5000, + genome="hg19", SNP= TRUE, + DataBase=Recon, + FAIMETest=TRUE, min_Intersect_Count=1) > > res.Disease <-runseq2pathway(inputfile=bed, + search_radius=5000, + genome="hg19", SNP= TRUE, + DataBase=Disease, + FAIMETest=TRUE, min_Intersect_Count=1) > save(res.GO, file="seq2pathway_OR.output.rData",compress=T) >
R code

Highlighted results
# FET found bone development related GO terms.
GOID 6 GO:0001649 Description 6 The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone.
Fisher_Pvalue Fisher_odds FDR Intersect_Count GO_gene_inBackground GO_gene_raw_Count 6 0.0007785541 4.56661 0.1450358 8 55 55 Intersect_gene 6 BMP2 BMP6 RUNX2 IGFBP5 MEF2C MSX2 NF1 WNT11 > > seq2pathway_BP_FET_P [9, ] GOID 11 GO:0030501 Description 11 Any process that activates or increases the frequency, rate or extent of bone mineralization.
Fisher_Pvalue Fisher_odds FDR Intersect_Count GO_gene_inBackground GO_gene_raw_Count 11 0.0007580774 6.424759 0.1450358 6 31 31 Intersect_gene 11 BMP2 BMP6 BMPR2 FBN2 MEF2C CD276 > # However, FAIME finds no significant GO term at the significance level of empirical p<0.01. # But with a moderate significance (p<0.05), FAIME can find two valuable GO terms predicted by # a comprehensive study on human height\cite{Wood14}. > > FAIME_BP <-res. GO 
RNA-seq data analysis
One advantage of the seq2pathway tool is that the pathway-level scores for each sample (hereafter termed profile) are systematic in the view of genome and individualized in the view of phenotype. This profile is individualized because the FAIME (Functional Analysis of Individual Microarray (or RNA-seq) Expression) algorithm [26] calculates the cumulative effects of genes inside a gene-set with the effects of those outside. The analysis of gene-sets is therefore superior to single-gene analysis in regard to noise and dimension reduction, as well as its desired biological interpretability.
We have recently systematically applied gene2pathway to a transcriptomic meta-analysis of samples from different laboratories [28] . In this case study, we demonstrate a simple two-group comparison of profiles between high-risk (n=10) and intermediate-risk (n=20) AML patients with cytogenetic abnormalities.
AML samples
We downloaded the available gene level RNA-seq data for 179 adult cases of de novo acute myeloid leukemia (AML) from the TCGA (The cancer genome atlas) on April 2014. The clinical information of these patients was obtained from the authors [19] . This data set was truncated into a simulation dataset and wrapped in the seq2pathway package. Following is demo code to run gene2pathway_test function to calculate an individualized gene-set score for MSigDB curated GO [17] .
Gene-set profile is independent of gene-set size
To verify the effects of gene length and genes-set size, we also performed the calculation on real data from 30 AML samples. We found no bias of gene-set size or gene length on the output gene-set scores calculated from RNA-seq data ( Figure 7 ).
Discover risk-dependent GO terms from AML patients with cytogenetic abnormalities.
As a demo case study, we simply call limma package to compare high-risk (n=10) and intermediate-risk (n=20) AML patients with cytogenetic abnormality. Not surprisingly, the FAIME algorithm found 10 curated GO terms, including "ACTIVATION OF IMMUNE RESPONSE" and "HOMOPHILIC CELL ADHESION". We split the gene2pathway output scores into eleven bins and the FAIME scores into 31 equal-sized bins. In each subpanel, the x-axis is the top value of each bin, and the y-axis is the log10 transformed gene-set size or gene length.
R code
RNA-seq is increasingly used for measuring gene expression levels. Normally, RNA-seq measures multiple samples from more than one sample-group. Based on expression on the gene-level, users can run the gene2pathway_test function and skip the runseq2gene() function.
Example 4: Pseudo-analysis of demo RNA-seq data
The inputs of the gene2pathway_test function running RNA-seq data will be a matrix of gene values and the output will be a matrix of pathway scores for multiple samples. > data(MsigDB_C5) > dat_gene2path_RNA <-gene2pathway_test(dat=dat_RNA, DataBase=MsigDB_C5, EmpiricalTest=F, method="FAIME", na.rm=T) > head(dat_gene2path_RNA$gene2pathway_result. 10 > # Calculate GO scores for each samples > > dat_gene2path_RNA <-gene2pathway_test(dat=dat, DataBase=MsigDB_C5, EmpiricalTest=F, method="FAIME", na.rm=T) > names(dat_gene2path_RNA) [1] In",20) ,rep("Hi",10))) > library(limma) > design=cbind("In"=as.integer(f=="In"), "Hi"=as.integer(f=="Hi")) > cont.matrix <-makeContrasts(Hi-In, levels=design) > fit <-lmFit(dat, design) > fit2 <-contrasts.fit(fit, cont.matrix) > fit2 <-eBayes(fit2) > output <-topTable(fit2, coef = 1. 
Take home points
There are several take home points that users should pay attention to.
First, the background Gene Ontologies are different among different approaches (Figure 8 ). So when comparing methods, it is important to consider the content of GO terms rather than the size of overlap. Second, we think that a customized filter on the"seq2gene" outputs for the study of likely cis-regulatory elementary element targets is critical when dealing with genomic region significance scores such as binding affinity estimates from ChIP-Seq.
Third, when applying gene2pathway analysis to selected gene list rather than the whole genome, one may user a smaller parameter α (by default is 5), allowing a moderate decay of weight from the most important genes to the least important genes in the list [28] (Figure 9 ). The effects of the parameter α on the FAIME scores. (A) Applying an increasingly larger α to the FAIME method. The weight (y-axis) is an exponential function of gene expression ranks (x-axis) adjusted by the parameter α. (B) Weight-dependent qualitative scores sharply increase with gene rank. The score (y-axis) is the product of gene expression ranks (x-axis) and the rank's weight adjusted by the parameter α. In each panel, the more highly expressed genes are ranked higher on the x-axis. The dashed line represents the score obtained with no weighting (i.e., ranking only) [28] .
In summary,
It is important to check and select the functional gene-set database before applying seq2pathway.
Seq2pathway is suitable to test gene-sets with three or more genes.
Seq2pathway overcomes common biases of SNP linkage disequilibrium, gene length, and gene-set size in pathway analysis of sequencing data.
We suggest performing a customized filter on the "seq2gene" outputs for the study of likely cis-regulatory elementary element targets.
In case novel functional element searching, we suggest a larger search radius ranging from 100 to 150 kbps, given that the average enhancer-promoter loop size is 120 kbps in mammalian genomes [3] and enhancers act in an orientation-independent manner [20] .
When applying gene2pathway analysis to selected gene list rather than the whole genome genes, one may user a smaller parameter alpha (rather than the by default value 5) [28] .
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